The MOTheR HDx trial and CONCORDIA observational study examined all-cause mortality after expanded hemodialysis using a medium cutoff dialyzer vs online hemodiafiltration.

Vera Therapeutics faces tough IgAN competition as Trutakna looks late and undifferentiated. A rich valuation adds risk. Read ...

Seasonal forecasts provide insight into conditions several months into the future. We provide a range of forecast maps. The ones most useful to you will depend on your needs. These forecasts can help ...

Detailed price information for Exxonmobil Holdings Corp (XOM-N) from The Globe and Mail including charting and trades.